(3S,7S,25S,28S)-33-(4-(4-(((2R,3S)-1-(((2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-12b-acetoxy-12-(benzoyloxy)-4,6,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxet-9-yl)oxy)-3-((tert-butoxycarbonyl)amino)-1-oxo-3-phenylpropan-2-yl)oxy)-4-oxobutyl)-1H-1,2,3-triazol-1-yl)-25-benzyl-12-(3-chlorobenzyl)-28-(4-hydroxybenzyl)-5,13,20,23,26,29-hexaoxo-4,6,12,19,24,27,30-heptaazatritriacontane-1,3,7-tricarboxylic acid

ID: ALA5184292

Chembl Id: CHEMBL5184292

PubChem CID: 168280182

Max Phase: Preclinical

Molecular Formula: C99H124ClN11O28

Molecular Weight: 1951.58

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@@]1(C)C(=O)[C@H](O)C3=C(C)[C@@H](OC(=O)[C@H](OC(=O)CCCc4cn(CCCNC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](Cc5ccccc5)NC(=O)CCC(=O)NCCCCCC(=O)N(CCCC[C@H](NC(=O)N[C@@H](CCC(=O)O)C(=O)O)C(=O)O)Cc5cccc(Cl)c5)nn4)[C@@H](NC(=O)OC(C)(C)C)c4ccccc4)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C

Standard InChI:  InChI=1S/C99H124ClN11O28/c1-58-72(54-99(133)86(137-91(129)64-31-17-11-18-32-64)84-97(8,85(122)82(121)80(58)96(99,6)7)73(114)53-74-98(84,57-134-74)138-59(2)112)135-92(130)83(81(63-29-15-10-16-30-63)107-94(132)139-95(3,4)5)136-79(120)37-24-34-66-56-111(109-108-66)49-25-47-102-87(123)70(52-61-38-40-67(113)41-39-61)104-88(124)71(51-60-26-13-9-14-27-60)103-76(116)44-43-75(115)101-46-21-12-19-36-77(117)110(55-62-28-23-33-65(100)50-62)48-22-20-35-68(89(125)126)105-93(131)106-69(90(127)128)42-45-78(118)119/h9-11,13-18,23,26-33,38-41,50,56,68-74,81-84,86,113-114,121,133H,12,19-22,24-25,34-37,42-49,51-55,57H2,1-8H3,(H,101,115)(H,102,123)(H,103,116)(H,104,124)(H,107,132)(H,118,119)(H,125,126)(H,127,128)(H2,105,106,131)/t68-,69-,70-,71-,72-,73-,74+,81-,82+,83+,84-,86-,97+,98-,99+/m0/s1

Standard InChI Key:  FEINPINWPCXTEY-MKNDYFMFSA-N

Alternative Forms

  1. Parent:

    ALA5184292

    ---

Associated Targets(Human)

CWR22R (2180 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-3 (62116 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DU-145 (51482 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Carboxylesterase (379 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1951.58Molecular Weight (Monoisotopic): 1949.8306AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Machulkin AE, Uspenskaya AA, Zyk NY, Nimenko EA, Ber AP, Petrov SA, Shafikov RR, Skvortsov DA, Smirnova GB, Borisova YA, Pokrovsky VS, Kolmogorov VS, Vaneev AN, Ivanenkov YA, Khudyakov AD, Kovalev SV, Erofeev AS, Gorelkin PV, Beloglazkina EK, Zyk NV, Khazanova ES, Majouga AG..  (2022)  PSMA-targeted small-molecule docetaxel conjugate: Synthesis and preclinical evaluation.,  227  [PMID:34717125] [10.1016/j.ejmech.2021.113936]

Source